CX Institutional’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.82M Buy
70,493
+1,846
+3% +$205K 0.27% 73
2025
Q1
$7.69M Buy
68,647
+4,360
+7% +$489K 0.29% 80
2024
Q4
$5.94M Buy
64,287
+3,300
+5% +$305K 0.24% 98
2024
Q3
$5.11M Buy
60,987
+15,545
+34% +$1.3M 0.23% 121
2024
Q2
$3.12M Sell
45,442
-2,446
-5% -$168K 0.15% 158
2024
Q1
$3.51M Buy
47,888
+1,024
+2% +$75K 0.17% 146
2023
Q4
$3.8M Buy
46,864
+7,680
+20% +$622K 0.2% 132
2023
Q3
$2.94M Sell
39,184
-19,811
-34% -$1.48M 0.16% 167
2023
Q2
$4.55M Buy
58,995
+2,411
+4% +$186K 0.24% 127
2023
Q1
$4.71M Buy
56,584
+48,011
+560% +$3.99M 0.25% 111
2022
Q4
$736K Buy
8,573
+889
+12% +$76.3K 0.04% 317
2022
Q3
$474K Sell
7,684
-28,164
-79% -$1.74M 0.03% 341
2022
Q2
$2.22M Buy
35,848
+3,207
+10% +$198K 0.17% 156
2022
Q1
$1.94M Sell
32,641
-4,566
-12% -$272K 0.16% 157
2021
Q4
$2.7M Sell
37,207
-14,837
-29% -$1.08M 0.21% 138
2021
Q3
$3.64M Buy
52,044
+700
+1% +$48.9K 0.3% 92
2021
Q2
$3.54M Buy
51,344
+3,254
+7% +$224K 0.29% 95
2021
Q1
$3.11M Buy
48,090
+46,333
+2,637% +$2.99M 0.28% 95
2020
Q4
$102K Buy
1,757
+747
+74% +$43.4K 0.01% 358
2020
Q3
$64K Buy
1,010
+140
+16% +$8.87K 0.01% 358
2020
Q2
$67K Buy
870
+57
+7% +$4.39K 0.01% 319
2020
Q1
$61K Buy
813
+428
+111% +$32.1K 0.01% 301
2019
Q4
$25K Sell
385
-477
-55% -$31K ﹤0.01% 326
2019
Q3
$55K Sell
862
-258
-23% -$16.5K 0.01% 289
2019
Q2
$76K Sell
1,120
-1,310
-54% -$88.9K 0.01% 293
2019
Q1
$158K Buy
2,430
+2,373
+4,163% +$154K 0.03% 230
2018
Q4
$4K Buy
+57
New +$4K ﹤0.01% 406